Lawrence Deyton - Concepedia

Author

Lawrence Deyton

National Institute of Allergy and Infectious Diseases

Also Known As

Grimes, Janet M., L Deyton, L. Deyton, Lawrence Deyton, Lawrence R Deyton, Lawrence R. Deyton

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases University of California, San Francisco George Washington University United States Food and Drug Administration National Institutes of Health

About

Lawrence Deyton is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Public Health	6	6	252
3	Health Sciences	2	2	38
4	Education	1	1	25
5	Community Health Sciences	1	1	13

Lawrence Deyton

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less Scott M. Hammer, Kathleen Squires, Michael D. Hughes, New England Journal of Medicine	1997	2.7K
ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA H. Clifford Lane, Judith Feinberg, Victoria J. Davey, The Lancet Human RetrovirusImmunodeficienciesImmunologyAntiviral ResponseVirology	1988	263
A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection Donald I. Abrams, Anne I. Goldman, Cynthia A. Launer, New England Journal of Medicine	1994	215
AIDS-related malignant lymphoma: results of prospective treatment trials. Parkash S. Gill, A Levine, Mark Krailo, Journal of Clinical Oncology Primary ImmunodeficiencyLymphoid NeoplasiaHuman RetrovirusMalignant Blood DisorderHematology	1987	196
Reversible Cardiac Dysfunction Associated with Interferon Alfa Therapy in AIDS Patients with Kaposi's Sarcoma Lawrence Deyton, Robert Walker, Joseph A. Kovacs, New England Journal of Medicine Heart FailureImmunologyAntiviral DrugImmunotherapyInterferon Therapy	1989	126
Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes Nandakumara Sarma, Andrew Waye, Mahmoud A. ElSohly, Journal of Natural Products	2020	106
Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future Corinne G. Husten, Lawrence Deyton The Lancet Public Health LawTobacco ControlTobacco CessationSubstance AbusePreventive Medicine	2013	78
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations Lisa I. Backus, Derek Boothroyd, Lawrence Deyton AIDS	2005	76
Tobacco Product Regulation — A Public Health Approach Lawrence Deyton, Joshua Sharfstein, Margaret Hamburg New England Journal of Medicine Tobacco CessationFamily MedicineHealth PreventionHealth LawHarm Reduction	2010	66
Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid Mark Holodniy, Scott Penzak, Timothy M. Straight, Antimicrobial Agents and Chemotherapy Oseltamivir ProphylaxisOseltamivir CombinedMedicineAntiviral Drug DevelopmentAntiviral Therapy	2008	59

Page 1